Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Background. Vinorelbine (VRB) and capecitabine (CAPE) are demonstrated to be active in pretreated metastatic breast cancer patients. Different studies have demonstrated that the metronomic treatment is active with an acceptable toxicity profile. We designed a Phases I-II study to define the MTD of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzaniga, M. E., Torri, V., Villa, F., Giuntini, N., Riva, F., Zeppellini, A., Cortinovis, D., Bidoli, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914392/
https://www.ncbi.nlm.nih.gov/pubmed/24551455
http://dx.doi.org/10.1155/2014/769790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914392/
https://www.ncbi.nlm.nih.gov/pubmed/24551455
http://dx.doi.org/10.1155/2014/769790

Ejemplares similares